Immunocore Holdings plc— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 vs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.07B | $1.01B |
| Current Assets | $997M | $930M |
| Cash | $468M | $456M |
| ST Investments | $396M | $365M |
| Receivables | $0 | $63M |
| Inventory | $7M | $5M |
| Other Current | $126M | $41M |
| Non-Current Assets | $71M | $80M |
| PPE | $11M | $10M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $59M | $70M |
| Total Liab+Eq | $1.07B | $1.01B |
| Current Liab. | $247M | $212M |
| Accounts Payable | $24M | $25M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $583K | $0 |
| Other CL | $222M | $187M |
| Non-Current Liab. | $440M | $437M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $440M | $437M |
| Equity | $381M | $361M |
| Retained Earnings | $831M | $796M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · IMCR · Comparing FY2025 vs FY2024